Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M K Owada

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
The Journal of Clinical Investigation|September 1, 1995
Tyrosine kinase inhibitor suppresses coronary arteriosclerotic changes and vasospastic responses induced by chronic treatment with interleukin-1 beta in pigs in vivoA Ito, H Shimokawa, T Kadokami, et al.
The American Journal of Physiology|July 1, 1996
Vanadate causes synthesis of endothelium-derived NO via pertussis toxin-sensitive G protein in pigsR Nakaike, H Shimokawa, M K Owada, et al.
The Journal of Biological Chemistry|December 16, 1994
Specificity of the high affinity interaction of protein kinase C with a physiological substrate, myristoylated alanine-rich protein kinase C substrateA Fujise, K Mizuno, Y Ueda, et al.
Cardiovascular Research|December 1, 1996
Tyrosine kinase inhibitor suppresses the (re) stenotic changes of the coronary artery after balloon injury in pigsY Fukumoto, H Shimokawa, T Kozai, et al.
Journal of Cardiovascular Pharmacology|November 1, 1996
The importance of the hyperpolarizing mechanism increases as the vessel size decreases in endothelium-dependent relaxations in rat mesenteric circulationH Shimokawa, H Yasutake, K Fujii, et al.
Journal of Cardiovascular Pharmacology|April 1, 1997
Tyrosine kinase inhibitor markedly suppresses the development of coronary lesions induced by long-term treatment with platelet-derived growth factor in pigs in vivoT Kozai, H Shimokawa, Y Fukumoto, et al.
Journal of Cardiovascular Pharmacology|February 1, 1997
Inflammatory cytokines cause coronary arteriosclerosis-like changes and alterations in the smooth-muscle phenotypes in pigsY Fukumoto, H Shimokawa, A Ito, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
The Journal of Clinical Investigation|September 1, 1995
Tyrosine kinase inhibitor suppresses coronary arteriosclerotic changes and vasospastic responses induced by chronic treatment with interleukin-1 beta in pigs in vivoA Ito, H Shimokawa, T Kadokami, et al.
The American Journal of Physiology|July 1, 1996
Vanadate causes synthesis of endothelium-derived NO via pertussis toxin-sensitive G protein in pigsR Nakaike, H Shimokawa, M K Owada, et al.
The Journal of Biological Chemistry|December 16, 1994
Specificity of the high affinity interaction of protein kinase C with a physiological substrate, myristoylated alanine-rich protein kinase C substrateA Fujise, K Mizuno, Y Ueda, et al.
Cardiovascular Research|December 1, 1996
Tyrosine kinase inhibitor suppresses the (re) stenotic changes of the coronary artery after balloon injury in pigsY Fukumoto, H Shimokawa, T Kozai, et al.
Journal of Cardiovascular Pharmacology|November 1, 1996
The importance of the hyperpolarizing mechanism increases as the vessel size decreases in endothelium-dependent relaxations in rat mesenteric circulationH Shimokawa, H Yasutake, K Fujii, et al.
Journal of Cardiovascular Pharmacology|April 1, 1997
Tyrosine kinase inhibitor markedly suppresses the development of coronary lesions induced by long-term treatment with platelet-derived growth factor in pigs in vivoT Kozai, H Shimokawa, Y Fukumoto, et al.
Journal of Cardiovascular Pharmacology|February 1, 1997
Inflammatory cytokines cause coronary arteriosclerosis-like changes and alterations in the smooth-muscle phenotypes in pigsY Fukumoto, H Shimokawa, A Ito, et al.
Pageof 4